<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">Surgical Margins (CoC)<br/>Residual Primary Tumor Following Cancer-Directed Surgery (pre-96 CoC)</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1320</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1574-1574</td>
    </tr>
</table>

<br/><b>Description</b><br/>
Codes describe the final status of surgical margins after resection of the primary tumor. See also RX Summ--Surg Prim Site [1290].

<br/><br/><b>Rationale</b><br/>
This item serves as a quality measure for pathology reports, is used for staging, and may be a prognostic factor in recurrence. This item is not limited to cases that have been staged. It applies to all cases that have a surgical procedure of the primary site.

<br/><br/><b>Codes (Refer to the most recent version  of <i>FORDS</i> for additional instructions.)</b><br/>
<table class="naaccr-codes-table">
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">0</td>
        <td class="naaccr-codes-cell">No residual tumor</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">1</td>
        <td class="naaccr-codes-cell">Residual tumor, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">2</td>
        <td class="naaccr-codes-cell">Microscopic residual tumor</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">3</td>
        <td class="naaccr-codes-cell">Macroscopic residual tumor</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">7</td>
        <td class="naaccr-codes-cell">Margins not evaluable</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">8</td>
        <td class="naaccr-codes-cell">No primary site surgery</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">9</td>
        <td class="naaccr-codes-cell">Unknown or not applicable</td>
    </tr>
</table>
<br/><i>Note:</i> Codes were site specific (1998-2002), and have been changed to be generic across all disease sites.
